Literature DB >> 11325911

New generation cardiac troponin I assay for the access immunoassay system.

P Venge1, B Lindahl, L Wallentin.   

Abstract

Mesh：

Substances：

Year:  2001        PMID： 11325911

Source DB:  PubMed          Journal:  Clin Chem        ISSN： 0009-9147            Impact factor:   8.327


× No keyword cloud information.
  6 in total

1.  "Upstream markers" provide for early identification of patients at high risk for myocardial necrosis and adverse outcomes.

Authors:  Peter A Kavsak; Dennis T Ko; Alice M Newman; Glenn E Palomaki; Viliam Lustig; Andrew R Macrae; Allan S Jaffe
Journal:  Clin Chim Acta       Date:  2007-10-03       Impact factor: 3.786

2.  The reporting of cardiac troponin.

Authors:  Peter E Hickman; Gus Koerbin; Jill Tate
Journal:  Clin Biochem Rev       Date:  2003-11

3.  Short- and long-term risk stratification using a next-generation, high-sensitivity research cardiac troponin I (hs-cTnI) assay in an emergency department chest pain population.

Authors:  Peter A Kavsak; Xuesong Wang; Dennis T Ko; Andrew R MacRae; Allan S Jaffe
Journal:  Clin Chem       Date:  2009-08-13       Impact factor: 8.327

4.  Elevated cardiac troponin in the early post-operative period and mortality following ruptured abdominal aortic aneurysm: a retrospective population-based cohort study.

Authors:  Ilana Kopolovic; Kimberley Simmonds; Shelley Duggan; Mark Ewanchuk; Daniel E Stollery; Sean M Bagshaw
Journal:  Crit Care       Date:  2012-08-07       Impact factor: 9.097

5.  Different roles for contracture and calpain in calcium paradox-induced heart injury.

Authors:  Jian-Ying Zhang; Wei Tong; Feng Wu; Sheng-Hui Bi; Ming Xu; Zhen-Xiao Jin; Yang Yang; Xiao-Fan Jiang; Jing-Jun Zhou
Journal:  PLoS One       Date:  2012-12-20       Impact factor: 3.240

6.  Risk factors and outcomes associated with acute kidney injury following ruptured abdominal aortic aneurysm.

Authors:  Ilana Kopolovic; Kim Simmonds; Shelley Duggan; Mark Ewanchuk; Daniel E Stollery; Sean M Bagshaw
Journal:  BMC Nephrol       Date:  2013-05-01       Impact factor: 2.388
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.